RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus-Immunotherapy combo takes on Hard-to-Treat cancers
Disease control OngoingThis study tests a cancer-killing virus (VSV-IFNβ-NIS) combined with the immunotherapy drug pembrolizumab in people with advanced solid tumors, including non-small cell lung cancer, neuroendocrine cancer, and kidney cancer. The goal is to find the safest and most effective virus …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1, PHASE2 • Sponsor: Vyriad, Inc. • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
New drug AB598 takes first steps against advanced cancers
Disease control OngoingThis early-phase study tests a new drug called AB598, alone or with other treatments, in about 40 people with advanced solid tumors like lung, bladder, or ovarian cancer. The main goal is to check if the drug is safe and tolerable. Participants must have measurable tumors and be …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 05:56 UTC
-
New hope for kidney cancer patients who Can't take standard drugs
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called AK112 for people with advanced kidney cancer that has spread. The drug helps the immune system fight cancer and blocks blood vessels that feed tumors. About 60 patients will receive the drug every three weeks to see if it shrinks tumors and …
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 05:46 UTC
-
Blood test may predict immunotherapy success in lung and kidney cancers
Knowledge-focused OngoingThis pilot study is testing whether changes in tumor DNA found in the blood can help doctors see if immunotherapy is working in patients with non-small cell lung cancer or kidney cancer. About 100 adults will give blood samples before and during their standard treatment. The goal…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:58 UTC